Genetically Engineered T-Cells Force Leukemia into Remission

A pretty amazing story indeed……13 people with a form of cancer called multiple myeloma were treated with genetically engineered T-Cells and all 13 are now in remission or close to it.  “The fact we got a response in all 13, you can’t get better than that,” says James Noble, CEO of Adaptimmune in Abingdon, UK, which developed the treatment.

The T-Cells can better recognise proteins called NY-ESO-1 and LAGE-1, these are found on myeloma cells only.  All 13 showed a boost in their white blood cell count.

We all probably know someone that has been taken b/c of cancer or is currently struggling with it.  It seems as though science has really made major strides in battling it, and we hope to hear more good news from this study after they’ve gone through additional trials.

Read more over at NewScientist.com

You may also like

Legislative panel approves medical malpractice bill
Read more
Urgent-care centers: Illinois numbers grow as time-pressed families seek low-cost option to ERs
Read more
Global Center for Medical Innovation launches
Read more

Recent Posts

Health Insurer Sued for Medical Malpractice Over Prior Authorization

North Carolina Supreme Court Removes Precedent Shielding Nurses from Medical Liability Claims

California Healthcare Providers, Trial Attorneys, Legislators Reach Deal to Increase MICRA Cap

Popular Posts

California Healthcare Providers, Trial Attorneys, Legislators Reach Deal to Increase MICRA Cap

2022 Medical Malpractice Insurance Rates: What the data tells us

Global Center for Medical Innovation launches

Start Your Custom Quote Process™

Request a free quote